Ingevity Corporation (NYSE:NGVT – Get Free Report) CEO David Li sold 5,000 shares of the business’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $76.62, for a total transaction of $383,100.00. Following the completion of the transaction, the chief executive officer owned 135,636 shares in the company, valued at $10,392,430.32. This represents a 3.56% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ingevity Trading Up 1.6%
Shares of NGVT opened at $76.53 on Friday. Ingevity Corporation has a one year low of $45.85 and a one year high of $79.29. The stock has a 50-day moving average price of $73.57 and a 200 day moving average price of $71.65. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61. The company has a market capitalization of $2.63 billion, a P/E ratio of 52.06 and a beta of 1.16.
Ingevity (NYSE:NGVT – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Sell-side analysts forecast that Ingevity Corporation will post 5.4 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
NGVT has been the topic of several research reports. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Ingevity currently has an average rating of “Hold” and an average price target of $80.00.
Get Our Latest Analysis on NGVT
About Ingevity
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Stories
- Five stocks we like better than Ingevity
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
